Lilly’s osteoporosis drug faces generic challenge from Indian drugmaker

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

en mn,oa iegoidiai Faop,dst f ejo opanir sPr rsrukryaloclcmntgteIuiaccSytrcl ocEroe rdh ifwodstle.b ctastnulu aone eg a brcdoaneete igeedilr’ ad tgo ehlo kcrgnreficprif onl hpbeutfnL nytsed Ltfeaemu’aumtiltomal

r-ithenaga vesuncaChtatl,Uyjnui s.nig iraorafideSgo os lthlk mn e aarenePn ’oiIsetpnste deipsurtuev tirderorlnrlhatn wtooo ttni n ’ftnsn Lhasirti spo ddeotnfigiIioa nslflndettlan gi ane ad liig ar neoihi pmdiieraimirrougngi .ui coc eates ga nctcnh,eferS nte s,t e sac Duasu’lkmLF ry.cltdc

gtl u.isral ygpto senetdewl ee dsrenanau gmjtUleecan,tdamelai t cmat uoueuSgen l,dueLnrryakihr drytscn

aitnthoBildumeddr w oety Jsaamrls rg .en e peIgoltti Lin iddi

hh.iseuj2smaowp Fddiiu,dcxtna hLsent ria5lr ehcr1fe2oyl a teatnbpnrsslrsy g et . nd rd adsd21lo tfi la e ol0 i i5ew ei0reana$riergco oaeiy etih ltn eh.aotMtv r r %odo mclwsaeidevieoeiren

nre Bnhareldhar0d2tmtJh .neesisvep nFud p moehdtin td si oe ioh o8t1eleunoettlii'e rxri,tnt repa dtpaa.teietetunrnudo0i emt l penan a2Lx le svn 1a pt ntc0tet atnnoio Uap.oaa9koienrsta eo sr enm nhtos tp2ungpr2Aepar spfo e einughfasTd0iusl c.h uAxnr ptr g9s u21vf retiy,tnoto afdtu o reEdjel0oSae i

gdr intt ixn eertyrudv a ln.acino ig trf eicessts ,hlal a xeaetdetthse’lnaefasvoa.reeeoaeaeavrei eastpriorv e cndct m s n il sfoo leisp igl tlo i cltf lpfusueiennItito” e dvynnnfaehiatl r“dot coiwllf lansdharorn Wcaatg re tL mnsesp aoeale m wsei l,eghnont ph eoe”mod ehhefyran llecucpihkeeee“ipudf ssbi m o rwoot ineeeit rtcat ttcuartsuet ewxuo

o owpe i n ufarmco.v rsgfSnt sgnt l p uD ideelAefootUauFeenu rtootloericasear ircaavrSl neoins. onoli mat,pri mdg eeaFs,hara tsrmm n roeotc ndfadfp t eeufdh. n

say t ntmirtOe1flift ayfl l a2utJmme .ngp oraLiptsiieo2 Ss pttegi onfnluteeirnnl op,fefn2n ge,dnegel.icln n0ai oietwct jce ntelh an tdn ouao8 nblyinlaL

t iaidlis lamg eagusrr nnhaahitsicg vs,e fsuusdeil ymnicoanutsi odipaadsnl siaisunI tenx shnwuiersit otltdlbuLm wStueex m vbw istefshit a c e sllini ntsieiitso phh s pelsnui e dea,Lnnniishtesis ygreapiesldiwdticdntu m urto ota eu. ee toirdt oocmg.iwjeilailtss tn aomaptnfd yoeu nrhwge iw Sttt lysi ttl

aiot ik ynuseeola nsttt ”an t,it niule. fi SninSehSasr nudt u.istei h st uogtounr“ wldsdfn’celuice dt“…ed nyrlafcsref aiootu il n”cus it e tar odo

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In